Kanikowska, D.; Korybalska, K.; Mickiewicz, A.; Rutkowski, R.; Kuchta, A.; Sato, M.; Kreft, E.; Fijałkowski, M.; Gruchała, M.; Jankowski, M.;
et al. Flaxseed (Linum Usitatissimum L.) Supplementation in Patients Undergoing Lipoprotein Apheresis for Severe Hyperlipidemia—A Pilot Study. Nutrients 2020, 12, 1137.
https://doi.org/10.3390/nu12041137
AMA Style
Kanikowska D, Korybalska K, Mickiewicz A, Rutkowski R, Kuchta A, Sato M, Kreft E, Fijałkowski M, Gruchała M, Jankowski M,
et al. Flaxseed (Linum Usitatissimum L.) Supplementation in Patients Undergoing Lipoprotein Apheresis for Severe Hyperlipidemia—A Pilot Study. Nutrients. 2020; 12(4):1137.
https://doi.org/10.3390/nu12041137
Chicago/Turabian Style
Kanikowska, Dominika, Katarzyna Korybalska, Agnieszka Mickiewicz, Rafał Rutkowski, Agnieszka Kuchta, Maki Sato, Ewelina Kreft, Marcin Fijałkowski, Marcin Gruchała, Maciej Jankowski,
and et al. 2020. "Flaxseed (Linum Usitatissimum L.) Supplementation in Patients Undergoing Lipoprotein Apheresis for Severe Hyperlipidemia—A Pilot Study" Nutrients 12, no. 4: 1137.
https://doi.org/10.3390/nu12041137
APA Style
Kanikowska, D., Korybalska, K., Mickiewicz, A., Rutkowski, R., Kuchta, A., Sato, M., Kreft, E., Fijałkowski, M., Gruchała, M., Jankowski, M., Bręborowicz, A., & Witowski, J.
(2020). Flaxseed (Linum Usitatissimum L.) Supplementation in Patients Undergoing Lipoprotein Apheresis for Severe Hyperlipidemia—A Pilot Study. Nutrients, 12(4), 1137.
https://doi.org/10.3390/nu12041137
